Thrombus formation reimagined.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. The Syk inhibitor BI 1002494 impairs thrombus infill in a murine femoral artery occlusion without affecting hemostasis.Blood vessels, thrombosis & hemostasis · 2025
   Article
2. Targeted SERPIN (TaSER): A dual-action antithrombotic agent that targets platelets for SERPIN delivery.Journal of thrombosis and haemostasis : JTH · 2022
   Article
3. Novel blood coagulation molecules: Skeletal muscle myosin and cardiac myosin.Journal of thrombosis and haemostasis : JTH · 2021
   Review
4. Activated protein C anticoagulant activity is enhanced by skeletal muscle myosin.Haematologica · 2020
   Article
5. In vivo measurement of blood clot mechanics from computational fluid dynamics based on intravital microscopy images.Computers in biology and medicine · 2019
   Article
6. Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic disease.The Journal of experimental medicine · 2017
   Article
7. Prothrombotic skeletal muscle myosin directly enhances prothrombin activation by binding factors Xa and Va.Blood · 2016
   Article

Corrections and comments

• Comment on
  New insights into the spatiotemporal localization of prothrombinase in vivo.2014
• Comment on
  A systems approach to hemostasis: 1. The interdependence of thrombus architecture and agonist movements in the gaps between platelets.2014
• Comment on
  A systems approach to hemostasis: 2. Computational analysis of molecular transport in the thrombus microenvironment.2014
• Comment on
  A systems approach to hemostasis: 3. Thrombus consolidation regulates intrathrombus solute transport and local thrombin activity.2014

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as